Manuel Sánchez Luna
Biographic Data
| ID | 7607368 |
|---|---|
| NAME | Manuel Sánchez Luna |
| GIVEN NAMES | Manuel Sánchez |
| FAMILY NAME | Luna |
| SIGNATURE | LUNA M S |
| AFFILIATIONS | Hospital General Universitario Gregorio Marañón |
| ORCID | 0000-0001-9543-7392 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 3 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
An implementation framework for planning an RSV immunization program for infants using the long-acting monoclonal antibody
Respiratory syncytial virus (RSV) infects most children by the age of two. Although the majority experience mild cold-like symptoms, RSV can lead to serious lower respiratory tract infections (LRTIs), including bronchiolitis and pneumonia; the virus is responsible for 3.6 million hospital admissions in children under five globally. More than 70% of RSV-related hospitalizations in children under 1 year of age occur in infants who are otherwise hea…
The effectiveness of nirsevimab in reducing the burden of disease due to respiratory syncytial virus (RSV) infection over time in the Madrid region (Spain)
Introduction: Respiratory syncytial virus (RSV) infection is one of the main causes of morbidity and mortality from lower respiratory tract infections in children under 5 years of age worldwide. Given that, the objective of this study was estimate the effectiveness of nirsevimab (a single-dose, long-acting, human recombinant monoclonal antibody against RSV) over time for the prevention of respiratory episodes treated at different levels of care. …
A Survey of the Union of European Neonatal and Perinatal Societies on Neonatal Respiratory Care in Neonatal Intensive Care Units
(1) Background: Our survey aimed to gather information on respiratory care in Neonatal Intensive Care Units (NICUs) in the European and Mediterranean region. (2) Methods: Cross-sectional electronic survey. An 89-item questionnaire focusing on the current modes, devices, and strategies employed in neonatal units in the domain of respiratory care was sent to directors/heads of 528 NICUs. The adherence to the "European consensus guidelines on the ma…
No prominent works on this page.
The effectiveness of nirsevimab in reducing the burden of disease due to respiratory syncytial virus (RSV) infection over time in the Madrid region (Spain)
Introduction: Respiratory syncytial virus (RSV) infection is one of the main causes of morbidity and mortality from lower respiratory tract infections in children under 5 years of age worldwide. Given that, the objective of this study was estimate the effectiveness of nirsevimab (a single-dose, long-acting, human recombinant monoclonal antibody against RSV) over time for the prevention of respiratory episodes treated at different levels of care. …
A Survey of the Union of European Neonatal and Perinatal Societies on Neonatal Respiratory Care in Neonatal Intensive Care Units
(1) Background: Our survey aimed to gather information on respiratory care in Neonatal Intensive Care Units (NICUs) in the European and Mediterranean region. (2) Methods: Cross-sectional electronic survey. An 89-item questionnaire focusing on the current modes, devices, and strategies employed in neonatal units in the domain of respiratory care was sent to directors/heads of 528 NICUs. The adherence to the "European consensus guidelines on the ma…
An implementation framework for planning an RSV immunization program for infants using the long-acting monoclonal antibody
Respiratory syncytial virus (RSV) infects most children by the age of two. Although the majority experience mild cold-like symptoms, RSV can lead to serious lower respiratory tract infections (LRTIs), including bronchiolitis and pneumonia; the virus is responsible for 3.6 million hospital admissions in children under five globally. More than 70% of RSV-related hospitalizations in children under 1 year of age occur in infants who are otherwise hea…
Disease (2 works) · Medicine (2 works) · Respiratory viral infections research (2 works) · Anesthesia (1 work) · Bronchiolitis (1 work) · Bronchopulmonary dysplasia (1 work) · Burden of disease (1 work) · Cohort (1 work) · Cohort study (1 work) · Continuous positive airway pressure (1 work)